New therapeutic approach shows promise for pediatric high-grade gliomas

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Brain tumors remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular are a mostly fatal disease group with a median survival time of less than 18 months after diagnosis and limited treatment options.